Using Magtrace for Breast Cancer Staging
Author Information
Author(s): Muacevic Alexander, Adler John R, Oweis Rami, Anil Aditya, Marinov Alexander, Hamati Tawfiq, Masudi Tahir
Primary Institution: The Rotherham NHS Foundation Trust
Hypothesis
Is the new Magtrace technique equivalent to the gold standard 99mTc technique for staging the axilla in early-stage breast cancer?
Conclusion
Magtrace is comparable to the standard technique in terms of practicality and risk of complications, with potential cost benefits.
Supporting Evidence
- The detection rate of SLNB was higher in the 99mTc group compared to the Magtrace group.
- Both groups had a similar number of lymph nodes retrieved during the procedure.
- The average duration of the surgical procedure was longer for the Magtrace group.
Takeaway
Doctors are testing a new method called Magtrace to see if it works as well as the old method for checking breast cancer spread, and it seems to do just as good a job.
Methodology
A single-center retrospective study comparing Magtrace and 99mTc techniques in 60 patients undergoing SLNB.
Limitations
The study has a small sample size and is retrospective in design.
Participant Demographics
Mean age of participants was 64.25 years, with a mix of tumor stages and histopathologies.
Statistical Information
P-Value
p=0.012
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website